CONCENTRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn...
Denise Iseri-Matsubara named executive director of Honolulu Office of Housing...
Mineros Announces Results of Ordinary Meeting of General Shareholders...
CGTN: 50 years on, China, Spain have profound friendship, achieve common...
US banks have US$620 billion of unrealised losses on their books
Denise Iseri-Matsubara named executive director of Honolulu Office of Housing...
Mineros Announces Results of Ordinary Meeting of General Shareholders...
CGTN: 50 years on, China, Spain have profound friendship, achieve common...
US banks have US$620 billion of unrealised losses on their books
Crispr Therapeutics
Business / FinanceBy Business Wire2023-03-31 14:00:00
Scribe Therapeutics Inc., a molecular engineering company enabling the creation of genetic medicines through its CRISPR by Design approach to genetic...
SciencePress Release2023-03-31 13:00:00
New Releases Extend the BioXp Select Product Line, Further Expanding the Utility, Speed, and Impact of the BioXp Automated Synthetic Biology Workstation SAN...
Press Release2023-03-31 18:54:00
Boca Raton, Florida--(Newsfile Corp. - March 31, 2023) - NovelStem International Corp. (OTC Pink: NSTM ), a development-stage company focused on the stem...
SciencePress Release2023-03-31 20:01:00
BOSTON, March 31, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to defeating cancer using RNA...
HealthPress Release2023-03-31 14:00:00
Celebrating a decade of backing Ontario entrepreneurs and advances in patient care TORONTO, March 31, 2023 /PRNewswire/ - FACIT is pleased to announce that...
Business / FinanceBy The Motley Fool2023-03-31 13:00:00
This Top Growth Stock Is Targeting a Multi-Billion-Dollar Market. Here's What It Means for Investors
Vertex Pharmaceuticals (NASDAQ: VRTX) has made a fortune developing medicines for cystic fibrosis (CF), a rare disease that causes damage to the lungs....
SciencePress Release2023-03-31 20:05:00
DURHAM, N.C., March 31, 2023 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE American: NHWK), a fully-integrated biopharmaceutical company focused on...
HealthPress Release2023-03-30 12:30:00
EAGAN, Minn., March 30, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology(NASDAQ: POAI), a science-driven company on the leading edge of oncology drug discovery...
HealthPress Release2023-03-30 12:11:21
RNA Based Therapeutic Market Research PORTLAND, OREGON, UNITED STATES, March 30, 2023 / EINPresswire.com / -- -
Business / FinanceBy Business Wire2023-03-31 13:20:00
Data from oral presentation adds to growing body of evidence supporting the profile of PRX012, which is designed to target all aggregated forms of amyloid...
SciencePress Release2023-03-31 12:30:00
Completed Enrollment in INOpulse REBUILD Phase 3 trial; Pivotal Top-line Data Expected in Mid-2023 Signed License Agreement with Baylor BioSciences to...
Business / FinanceBy Business Wire2023-03-31 20:31:00
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Adicet Bio (NASDAQ:ACET)
Adicet Bio, Inc. ACET, a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced...
SciencePress Release2023-03-31 12:00:00
SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed...
HealthPress Release2023-03-30 12:00:00
BOSTON, March 30, 2023 /PRNewswire/ -- Combined Therapeutics Inc. (CTx), a privately held biotechnology company developing the next generation of mRNA...
Business / FinanceBy Rtt News2023-03-27 12:37:27
(RTTNews) - Biotechnology company Vertex Pharmaceuticals, Inc. (VRTX) and gene editing company CRISPR Therapeutics, Inc. (CRSP) announced Monday that they...
Business / FinanceBy Business Wire2023-03-31 22:25:00
Sarepta Therapeutics, Inc. SRPT, the leader in precision genetic medicine for rare diseases, granted equity awards on March 31, 2023 that were previously...
SciencePress Release2023-03-31 20:05:00
CAMBRIDGE, Mass., March 31, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc.(Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused...
SciencePress Release2023-03-31 22:49:00
FREMONT, CA, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (Nasdaq: ABVC), a biotechnology company specializing in botanically...
EconomyPress Release2023-03-31 13:30:00
Chicago, March 31, 2023 (GLOBE NEWSWIRE) -- The future of biomarkers is expected to be a very promising one. As new technologies and techniques continue to...
Business / FinanceBy Benzinga Insights2023-03-31 14:48:22
Biora Therapeutics BIOR brought in sales totaling $14 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 168.32%,...